PROK (STOCKS)
ProKidney Corp. Class A Ordinary Shares
$1.955000
+0.005000 (+0.26%)
Prev close: $1.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bruce Culleton
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $590.25M
- Employees
- 204
- P/E (TTM)
- -3.78
- P/B (TTM)
- -0.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
5
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.14 | $-0.12 | -0.0160 | -12.90% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.13 | +0.0146 | +10.85% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.15 | +0.0169 | +11.50% |
|
Mar 2025 (Q1)
|
$-0.13 | $-0.16 | +0.0307 | +19.10% |
Financial Statements
| Revenues | $893.00K |
| Benefits Costs and Expenses | $152.09M |
| Costs And Expenses | $152.09M |
| Operating Expenses | $165.90M |
| Research and Development | $114.12M |
| Other Operating Expenses | $51.78M |
| Operating Income/Loss | -$165.01M |
| Income/Loss From Continuing Operations After Tax | -$151.61M |
| Income/Loss From Continuing Operations Before Tax | -$151.20M |
| Income Tax Expense/Benefit | $414.00K |
| Interest Expense, Operating | $4.00K |
| Net Income/Loss | -$151.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$82.63M |
| Net Income/Loss Attributable To Parent | -$68.99M |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | -$82.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$68.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $335.57M |
| Current Assets | $280.68M |
| Noncurrent Assets | $54.90M |
| Fixed Assets | $51.23M |
| Other Non-current Assets | $3.66M |
| Liabilities | $34.78M |
| Current Liabilities | $30.74M |
| Accounts Payable | $940.00K |
| Other Current Liabilities | $29.80M |
| Noncurrent Liabilities | $4.04M |
| Redeemable Noncontrolling Interest | $1.31B |
| Redeemable Noncontrolling Interest, Other | $1.31B |
| Equity | -$1.01B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$1.01B |
| Temporary Equity | $1.31B |
| Liabilities And Equity | $335.57M |
| Net Cash Flow From Operating Activities | -$120.12M |
| Net Cash Flow From Operating Activities, Continuing | -$120.12M |
| Net Cash Flow From Investing Activities | $103.97M |
| Net Cash Flow From Investing Activities, Continuing | $103.97M |
| Net Cash Flow From Financing Activities | $25.57M |
| Net Cash Flow From Financing Activities, Continuing | $25.57M |
| Net Cash Flow | $9.42M |
| Net Cash Flow, Continuing | $9.42M |
| Comprehensive Income/Loss | -$151.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$82.72M |
| Comprehensive Income/Loss Attributable To Parent | -$69.06M |
| Other Comprehensive Income/Loss | -$164.00K |